115 related articles for article (PubMed ID: 16595594)
1. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
Chalasani N; Vuppalanchi R; Raikwar NS; Deeg MA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2279-85. PubMed ID: 16595594
[TBL] [Abstract][Full Text] [Related]
2. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
3. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
Bowen RF; Raikwar NS; Olson LK; Deeg MA
Metabolism; 2001 Dec; 50(12):1489-92. PubMed ID: 11735099
[TBL] [Abstract][Full Text] [Related]
4. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
5. [Expression and activity of glycosylphosphatidylinositol-specific phospholipase d mRNA in bone marrow mononuclear cells isolated from patient with acute myeloid leukemia and their significance].
Xiao GF; Tang XY; Li X; Zeng C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):15-8. PubMed ID: 20137110
[TBL] [Abstract][Full Text] [Related]
6. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D.
Flores-Borja F; Kieszkievicz J; Church V; Francis-West PH; Schofield J; Rademacher TW; Lund T
Biochimie; 2004; 86(4-5):275-82. PubMed ID: 15194230
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
8. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes.
Deeg MA; Bowen RF; Williams MD; Olson LK; Kirk EA; LeBoeuf RC
Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E147-54. PubMed ID: 11404232
[TBL] [Abstract][Full Text] [Related]
10. GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy.
Xiaotong H; Hannocks MJ; Hampson I; Brunner G
Clin Exp Metastasis; 2002; 19(4):291-9. PubMed ID: 12090469
[TBL] [Abstract][Full Text] [Related]
11. Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D.
Deeg MA; Raikwar NS; Johnson C; Williams CD
Transl Res; 2007 Sep; 150(3):153-7. PubMed ID: 17761367
[TBL] [Abstract][Full Text] [Related]
12. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism.
Mann KJ; Hepworth MR; Raikwar NS; Deeg MA; Sevlever D
Biochem J; 2004 Mar; 378(Pt 2):641-8. PubMed ID: 14611645
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation of GPLD1 associates with serum GPI-PLD levels: a preliminary study.
Deeg MA; Xuei X; Eckert G; Considine RV; Li YG; Pratt JH
Biochim Biophys Acta; 2012 Mar; 1821(3):381-5. PubMed ID: 22260953
[TBL] [Abstract][Full Text] [Related]
15. Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance.
Raikwar NS; Bowen-Deeg RF; Du XS; Low MG; Deeg MA
Metabolism; 2010 Oct; 59(10):1413-20. PubMed ID: 20153004
[TBL] [Abstract][Full Text] [Related]
16. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of glycosylphosphatidylinositol-specific phospholipase D induced by lipopolysaccharide and oxidative stress in the murine monocyte- macrophage cell line RAW 264.7.
Du X; Low MG
Infect Immun; 2001 May; 69(5):3214-23. PubMed ID: 11292743
[TBL] [Abstract][Full Text] [Related]
18. Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes.
O'Brien KD; Pineda C; Chiu WS; Bowen R; Deeg MA
Circulation; 1999 Jun; 99(22):2876-82. PubMed ID: 10359731
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D.
Kurtz TA; Fineberg NS; Considine RV; Deeg MA
Metabolism; 2004 Feb; 53(2):138-9. PubMed ID: 14767861
[TBL] [Abstract][Full Text] [Related]
20. Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization.
LeBoeuf RC; Caldwell M; Guo Y; Metz C; Davitz MA; Olson LK; Deeg MA
Mamm Genome; 1998 Sep; 9(9):710-4. PubMed ID: 9716655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
